Matthew Zirwas, MD

Articles by Matthew Zirwas, MD

AD Treatment Options for Patients Moving Away from Long-Term Steroids

ByRaj Chovatiya, MD, PhD,Matthew Zirwas, MD,Adelaide A. Hebert, MD,Omar Noor, MD,Peter Lio, MD

February 8th 2023

Peter A. Lio, MD, shares his approach to presenting treatment alternatives to patients who want to stop using long-term steroids for treatment of AD.

Challenges Faced by Non-Dermatologists When Using Steroids

ByRaj Chovatiya, MD, PhD,Matthew Zirwas, MD,Adelaide A. Hebert, MD,Omar Noor, MD,Peter Lio, MD

February 8th 2023

Adelaide A. Hebert, MD, comments on the need for nondermatologist education on the basics of skin disease care.

Durability of Topical Steroid Use in AD

ByRaj Chovatiya, MD, PhD,Matthew Zirwas, MD,Adelaide A. Hebert, MD,Omar Noor, MD,Peter Lio, MD

February 1st 2023

Expert dermatologists discuss the durability of long-term use of topical steroids for treatment of atopic dermatitis.

Patient on Long-Term Steroidal Use in AD

ByRaj Chovatiya, MD, PhD,Matthew Zirwas, MD,Adelaide A. Hebert, MD,Omar Noor, MD,Peter Lio, MD

February 1st 2023

Adelaide A. Hebert, MD, reviews the use of long-term steroids for treatment of atopic dermatitis.

Factors Guiding Treatment Selection in AD

ByRaj Chovatiya, MD, PhD,Matthew Zirwas, MD,Adelaide A. Hebert, MD,Omar Noor, MD,Peter Lio, MD

January 26th 2023

Experts in dermatology discuss which disease characteristics play the biggest role in influencing treatment choice or change of treatment from the perspective of a patient with atopic dermatitis.

Treatment Options and Targets in Atopic Dermatitis (AD)

ByRaj Chovatiya, MD, PhD,Matthew Zirwas, MD,Adelaide A. Hebert, MD,Omar Noor, MD,Peter Lio, MD

January 25th 2023

A panel of expert dermatologists comments on newly approved and traditional treatment options, addressing how they target inflammation and the pathophysiology of atopic dermatitis (AD).